FDA NDC Directory · JSON-LD · Markdown

Chaetomium globosum

NDC 22840-1650 · NON-STANDARDIZED ALLERGENIC · SOLUTION

Labeler / ManufacturerGreer Laboratories, Inc.
Marketing categoryBiologic License Application · App BLA101833
Dosage form / routeSOLUTION · INTRADERMAL PERCUTANEOUS SUBCUTANEOUS
Active ingredientsCHAETOMIUM GLOBOSUM (20000 [PNU]/mL)
Marketing started19810915
Package count1

External sources

Source: openFDA. Public-domain (CC0).